Canada is emerging as a global leader in psychedelic research, with groundbreaking studies happening across the country. At MAPS Canada, we are committed to supporting and promoting this important work wherever possible—helping to advance science, inform policy, and create a more compassionate, evidence-based future for psychedelic medicine.
Click here to search for clinical trials registered with Health Canada:
Click here to view an interactive map of clinical trials in Canada,
(and worldwide):
PSYCHEDELIC STUDIES CURRENTLY RECRUITING PARTICIPANTS
This list was compiled to highlight studies currently recruiting participants for psychedelic clinical trials in Canada.
Please note: MAPS Canada is not affiliated with the studies listed below, nor is this a comprehensive list. Click ‘Study information’ for contact or ‘Learn more’ to view the study page.
ALBERTA
Attitudes and Beliefs Toward Psychedelic-Assisted Therapies (PAT) for Cancer-Related Psychosocial Symptoms in Healthcare Providers, Patients and Policy Makers
Institution conducting study: The University of Calgary
Study contact: haley.mather@ucalgary.ca
Mechanisms supporting Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder: A randomized, controlled clinical trial
Institution conducting study: The University of Calgary
Study contact: pactlab@ucalgary.ca
Psilocybin for Alcohol Use Disorder
Institution conducting study: The University of Calgary
Study Contact: pactlab@ucalgary.ca
BRITISH COLUMBIA
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Institution conducting study: atai Therapeutics, Inc
Study contact: Surrey, BC: CNSNeuroStudies@gmail.com
Kingston, ON: vazquep@providencecare.ca
Standardized Natural Psilocybin-Assisted Psychotherapy for Opioid Medication
Institution conducting study: The University of British Columbia
Study Contact: doclouw@mail.ubc.ca
ONTARIO
A Randomized Neuroimaging Trial of Psilocybin in Depression (EMBRACE)
Institution conducting study: Sunnybrook Health Sciences Centre
Study contact: embrace@sunnybrook.ca
A Randomized Trial of MDMA-Assisted Cognitive-Behavioural Conjoint Therapy (CBCT) versus CBCT in Dyads in Which One Member has Posttraumatic Stress Disorder (PTSD)
Institution conducting study: Remedy Institute
Study contact: research@remedyinstitute.ca
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Institution conducting study: CAMH: The Centre for Addiction and Mental Health
Study contact: gwyneth.zai@camh.ca
Looking for Higher Consciousness: The Effects of Psilocybin on Top-Down Visual Illusions and Cognition
Institution conducting study: Western University
Psilocybin-Assisted Existential, Attachment and RelationaL (PEARL) Therapy for End-of-Life Distress in Patients with Advanced Cancer
Institution conducting study: University Health Network
Study Contact: cindy.chan@uhn.ca
Psilocybin in the Treatment of Cannabis Use Disorder
Institution conducting study: MacAnxiety Research Centre
Study contact: rahatvam@mcmaster.ca
Relationship between Psychedelic Use, Insight and Psychological Wellbeing
Institution conducting study: University of Toronto
Study contact: insight.wellbeing.study@gmail.com
The Risks and Benefits of Using 5-MeO-DMT in a Retreat Setting
Institution conducting study: University Health Network
Study Contact: emma.hapke@uhn.ca
University Health Network Psychedelic Psychotherapy Research Group (UHN PPRG) - Ayahuasca Experiences
Institution conducting study: University Health Network